1
|
Watz CG, Moacă EA, Cioca A, Șuta LM, Krauss Maldea L, Magyari-Pavel IZ, Nicolov M, Sîrbu IO, Loghin F, Dehelean CA. Cutaneous Evaluation of Fe 3O 4 Nanoparticles: An Assessment Based on 2D and 3D Human Epidermis Models Under Standard and UV Conditions. Int J Nanomedicine 2025; 20:3653-3670. [PMID: 40130196 PMCID: PMC11932040 DOI: 10.2147/ijn.s513423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2024] [Accepted: 03/11/2025] [Indexed: 03/26/2025] Open
Abstract
Purpose The high-speed development of nanotechnology industry has fueled a plethora of engineered nanoparticles (NPs) and NP-based consumer products, further leading to massive and uncontrolled human exposure. In this regard, the researches addressing the safety assessment of NPs should be re-approached from the perspective of test parameters variety, closely simulating daily life scenarios. Therefore, the present study adopts complex in vitro models to establish the safety profile of Fe3O4 NPs, by using 2D and 3D human epidermis models under both standard and UV exposure conditions. Methods Advanced 3D human reconstructed epidermal tissues and two different monolayers of immortalized human cells (keratinocytes and fibroblasts), using series of in vitro assays were employed in the current study to evaluate multiple biological responses, as follows: i) divers protocols (skin irritation, phototoxicity assay); ii) different conditions (± UV exposure) and iii) a wide variety of quantification methods, such as: MTT, NR and LDH colorimetric tests - performed to evaluate the viability of the cells/microtissues, respectively, the cytotoxicity of the test compounds. In addition, IL-1α ELISA assay was used to quantify the inflammatory activity induced by the test samples, while immunocytochemistry analysis through fluorescent microscopy was employed to provide insightful information regarding the possible mechanism of action of test samples. Results The two test samples (S1 and S2) induced a higher cell viability decrease on immortalized human keratinocytes (HaCaT) compared to human fibroblasts (1BR3), while 3D-epidermis microtissues showed similar viabilities when treated with both samples under standard conditions (-UV rays) - for both type of evaluation protocols: skin irritation and phototoxicity. However, UV irradiation of 3D-microtissues pre-exposed to test samples led to different results between the two test samples, revealing that S2 sample induced a significant impairment of human epidermis viability, whereas S1 sample elicited an activity similar to the one recorded under standard conditions (-UV). Conclusion The present results indicate significant differences in toxicity between the two in vitro models under UV conditions, highlighting the importance of model selection and exposure parameters in assessing NP safety. Thus, our findings suggest that Fe3O4 NPs may pose some risks under specific environmental conditions, within the limitations of the experimental setup, and further research is needed to refine safety guidelines.
Collapse
Affiliation(s)
- Claudia Geanina Watz
- Doctoral School, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
- Department of Pharmaceutical Physics, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
- Center for Drug Data Analysis, Cheminformatics and the Internet of Medical Things, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
- Research Center for Pharmaco-Toxicological Evaluation, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Elena-Alina Moacă
- Research Center for Pharmaco-Toxicological Evaluation, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Andreea Cioca
- Department of Pathology “Regina Maria” Health Network, Timisoara, 300645, Romania
| | - Lenuța Maria Șuta
- Pharmaceutical Technology, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Lavinia Krauss Maldea
- Department of Pharmaceutical Physics, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Ioana Zinuca Magyari-Pavel
- Department of Pharmacognosy-Phytotherapy, “Victor Babes” University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania
- Research and Processing Center for Medicinal and Aromatic Plants, “Victor Babeș” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Mirela Nicolov
- Department of Pharmaceutical Physics, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
- Center for Drug Data Analysis, Cheminformatics and the Internet of Medical Things, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| | - Ioan-Ovidiu Sîrbu
- Department of Biochemistry, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania
- Complex Network Science Center, “Victor Babes” University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania
| | - Felicia Loghin
- Department of Toxicology, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy of Cluj-Napoca, Cluj-Napoca, 400012, Romania
| | - Cristina A Dehelean
- Research Center for Pharmaco-Toxicological Evaluation, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, Timisoara, 300041, Romania
| |
Collapse
|
2
|
Forest V. Experimental and Computational Nanotoxicology-Complementary Approaches for Nanomaterial Hazard Assessment. NANOMATERIALS 2022; 12:nano12081346. [PMID: 35458054 PMCID: PMC9031966 DOI: 10.3390/nano12081346] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 04/07/2022] [Accepted: 04/12/2022] [Indexed: 12/25/2022]
Abstract
The growing development and applications of nanomaterials lead to an increasing release of these materials in the environment. The adverse effects they may elicit on ecosystems or human health are not always fully characterized. Such potential toxicity must be carefully assessed with the underlying mechanisms elucidated. To that purpose, different approaches can be used. First, experimental toxicology consisting of conducting in vitro or in vivo experiments (including clinical studies) can be used to evaluate the nanomaterial hazard. It can rely on variable models (more or less complex), allowing the investigation of different biological endpoints. The respective advantages and limitations of in vitro and in vivo models are discussed as well as some issues associated with experimental nanotoxicology. Perspectives of future developments in the field are also proposed. Second, computational nanotoxicology, i.e., in silico approaches, can be used to predict nanomaterial toxicity. In this context, we describe the general principles, advantages, and limitations especially of quantitative structure–activity relationship (QSAR) models and grouping/read-across approaches. The aim of this review is to provide an overview of these different approaches based on examples and highlight their complementarity.
Collapse
Affiliation(s)
- Valérie Forest
- Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, Etablissement Français du Sang, INSERM, U1059 Sainbiose, Centre CIS, F-42023 Saint-Etienne, France
| |
Collapse
|